National Health Investors (NHI) Expected to Announce Earnings on Thursday

National Health Investors (NYSE:NHI) will likely be releasing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect National Health Investors to post earnings of $1.21 per share and revenue of $85.6550 million for the quarter. Interested persons may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Friday, November 7, 2025 at 10:00 AM ET.

National Health Investors (NYSE:NHI) last released its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating the consensus estimate of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The firm had revenue of $70.27 million during the quarter, compared to analysts’ expectations of $86.46 million. During the same period in the prior year, the company earned $1.18 EPS. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, analysts expect National Health Investors to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

National Health Investors Trading Down 2.1%

Shares of NHI stock opened at $73.53 on Thursday. National Health Investors has a 52-week low of $65.13 and a 52-week high of $82.32. The stock has a market cap of $3.49 billion, a price-to-earnings ratio of 23.49, a P/E/G ratio of 3.38 and a beta of 0.77. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91. The firm has a fifty day moving average of $77.06 and a 200-day moving average of $74.35.

National Health Investors Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a $0.92 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.0%. This is a positive change from National Health Investors’s previous quarterly dividend of $0.90. National Health Investors’s dividend payout ratio is currently 117.57%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Cantor Fitzgerald assumed coverage on shares of National Health Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price objective for the company. KeyCorp upgraded shares of National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 price objective for the company in a research note on Thursday, July 10th. National Bankshares set a $90.00 price objective on shares of National Health Investors in a research note on Wednesday, October 1st. Weiss Ratings restated a “buy (b-)” rating on shares of National Health Investors in a research note on Wednesday, October 8th. Finally, Truist Financial increased their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research note on Friday, August 15th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $84.83.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. EverSource Wealth Advisors LLC boosted its stake in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares during the last quarter. NewEdge Advisors LLC raised its position in shares of National Health Investors by 28.7% in the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 345 shares during the period. Osaic Holdings Inc. raised its position in shares of National Health Investors by 24.1% in the 2nd quarter. Osaic Holdings Inc. now owns 1,629 shares of the real estate investment trust’s stock valued at $115,000 after acquiring an additional 316 shares during the period. BNP Paribas Financial Markets raised its position in shares of National Health Investors by 54.4% in the 2nd quarter. BNP Paribas Financial Markets now owns 4,334 shares of the real estate investment trust’s stock valued at $304,000 after acquiring an additional 1,527 shares during the period. Finally, Cetera Investment Advisers raised its position in shares of National Health Investors by 6.1% in the 2nd quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock valued at $336,000 after acquiring an additional 275 shares during the period. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.